C

Coeptis Therapeutics Holdings
D

COEP

0.19900
USD
0.00
(2.37%)
مغلق
حجم التداول
0
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
7,904,000
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Coeptis Therapeutics Holdings

القطاع: Healthcare
الصناعة: Biotechnology
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.